[New aspects in thyroid cancer treatment : Highlights of the ASCO Annual Meeting 2018].

[New aspects in thyroid cancer treatment : Highlights of the ASCO Annual Meeting 2018]. HNO. 2018 Nov 06;: Authors: Möckelmann N, Münscher A Abstract Whereas surgical treatment of thyroid carcinoma plays an important role especially in the early stages, a multimodal approach is pursued in the palliative setting, which, in addition to classical chemotherapy primarily involves treatment with tyrosine kinase inhibitors. An analysis of clinical trials and studies presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 is presented. In particular, studies on the treatment of radioiodine-refractory differentiated thyroid cancer, anaplastic thyroid cancer and immunotherapy were selected and analyzed. Clinically and preclinically relevant studies are presented and critically interpreted in this review. PMID: 30402812 [PubMed - as supplied by publisher]
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research